Endothelial Dysfunction in Metabolic and Vascular Disorders

References

• . Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115(10):1285–1295
   PubMed Web of Science ®Google Scholar
• . Lahoz C, Mostaza JM. Atherosclerosis as a systemic disease. Rev Esp Cardiol. 2007;60(2):184–195
   PubMed Web of Science ®Google Scholar
• . Nicolls MR, Haskins K, Flores SC. Oxidant stress, immune dysregulation, and vascular function in type I diabetes. Antioxid Redox Signal. 2007;9(7):879–899
   PubMed Web of Science ®Google Scholar
• . Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulindependent diabetes mellitus. Circulation. 1993;88(6):2510–2516
   PubMed Web of Science ®Google Scholar
• . Gupta AK, Ravussin E, Johannsen DL, Stull AJ, Cefalu WT, Johnson WD. Endothelial dysfunction: an early cardiovascular risk marker in asymptomatic obese individuals with prediabetes. Br J Med Med Res. 2012;2(3):413–423
   PubMedGoogle Scholar
• . Lteif AA, Han K, Mather KJ. Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks. Circulation. 2005;112(1):32–38
   PubMed Web of Science ®Google Scholar
• . Hamburg NM, Larson MG, Vita JA, . Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol. 2008;101(1):82–88
   PubMed Web of Science ®Google Scholar
• . Badimon L, Martínez-González J, Llorente-Cortés V, Rodríguez C, Padró T. Cell biology and lipoproteins in atherosclerosis. Curr Mol Med. 2006;6(5):439–456
   PubMed Web of Science ®Google Scholar
• . Sprung VS, Atkinson G, Cuthbertson DJ, . Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies. Clin Endocrinol (Oxf). 2013;78(3):438–446
   PubMed Web of Science ®Google Scholar
• . Park JH, Jin YM, Hwang S, Cho DH, Kang DH, Jo I. Uric acid attenuates nitric oxide production by decreasing the interaction between endothelial nitric oxide synthase and calmodulin in human umbilical vein endothelial cells: a mechanism for uric acid-induced cardiovascular disease development. Nitric Oxide. 2013;32:36–42
   PubMed Web of Science ®Google Scholar
• . Mercuro G, Vitale C, Cerquetani E, . Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol. 2004;94(7):932–935
   PubMed Web of Science ®Google Scholar
• . Wu HD, Berglund L, Dimayuga C, . High lipoprotein(a) levels and small apolipoprotein(a) sizes are associated with endothelial dysfunction in a multiethnic cohort. J Am Coll Cardiol. 2004;43(10):1828–1833
   PubMed Web of Science ®Google Scholar
• . Schachinger V, Halle M, Minners J, Berg A, Zeiher AM. Lipoprotein(a) selectively impairs receptor-mediated endothelial vasodilator function of the human coronary circulation. J Am Coll Cardiol. 1997;30(4):927–934
   PubMed Web of Science ®Google Scholar
• . Bogdanski P, Miller-Kasprzak E, Pupek-Musialik D, . Plasma total homocysteine is a determinant of carotid intima-media thickness and circulating endothelial progenitor cells in patients with newly diagnosed hypertension. Clin Chem Lab Med. 2012;50(6):1107–1113
   PubMed Web of Science ®Google Scholar
• . Kim CS, Kim YR, Naqvi A, . Homocysteine promotes human endothelial cell dysfunction via site-specific epigenetic regulation of p66 shc. Cardiovasc Res. 2011;92(3):466–475
   PubMed Web of Science ®Google Scholar
• . Türemen EE, Çetinarslan B, Şahin T, Cantürk Z, Tarkun İ. Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. Endocr J. 2011;58(5):349–354
   PubMed Web of Science ®Google Scholar
• . Napoli R, Guardasole V, Zarra E, . Impaired endothelial- and nonendothelial-mediated vasodilation in patients with acute or chronic hypothyroidism. Clin Endocrinol (Oxf). 2010;72(1):107–111
   PubMed Web of Science ®Google Scholar
• . Chandran DS, Jaryal AK, Jyotsna VP, Deepak KK. Impaired endothelium mediated vascular reactivity in endogenous Cushing's syndrome. Endocr J. 2011;58(9):789–799
   PubMed Web of Science ®Google Scholar
• . Wu VC, Lo SC, Chen YL, ; TAIPAI Study Group. Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis. J Clin Endocrinol Metab. 2011;96(10):3175–3183
   PubMed Web of Science ®Google Scholar
• . Francque S, Laleman W, Verbeke L, . Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture. Lab Invest. 2012;92(1):1428–1439
   PubMedGoogle Scholar
• . Thakur ML, Sharma S, Kumar A, . Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. Atherosclerosis. 2012;223(2):507–511
   PubMed Web of Science ®Google Scholar
• . Berzigotti A, Erice E, Gilabert R, . Cardiovascular risk factors and systemic endothelial function in patients with cirrhosis. Am J Gastroenterol. 2013;108(1):75–82
   PubMed Web of Science ®Google Scholar
• . Recio-Mayoral A, Banerjee D, Streather C, Kaski JC. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease—a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis. 2011;216(2):446–451
   PubMed Web of Science ®Google Scholar
• . Banerjee D, Recio-Mayoral A, Chitalia N, Kaski JC. Insulin resistance, inflammation, and vascular disease in nondiabetic predialysis chronic kidney disease patients. Clin Cardiol. 2011;34(6):360–365
   PubMed Web of Science ®Google Scholar
• . Beckman JA, Creager MA, Libbiy P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287(19):2570–2581
   PubMed Web of Science ®Google Scholar
• . Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288(5789):373–376
   PubMed Web of Science ®Google Scholar
• . Moncada S, Palmer RM, Higgs EA. The discovery of nitric oxide as the endogenous nitrovasodilatator. Hypertension. 1988;12(4):365–372
   PubMed Web of Science ®Google Scholar
• . Förstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33(7):829–837
   PubMed Web of Science ®Google Scholar
• . Klatt P, Pfeiffer S, List BM, . Characterization of heme-deficient neuronal nitric-oxide synthase reveals a role for heme in subunit dimerization and binding of the amino acid substrate and tetrahydrobiopterin. J Biol Chem. 1996;271(13):7336–7342
   PubMed Web of Science ®Google Scholar
• . Abu-Soud HM, Stuehr DJ. Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc Natl Acad Sci USA. 1993;90(22):10769–10772
   PubMed Web of Science ®Google Scholar
• . Pritchard KA Jr, Ackerman AW, Gross ER, . Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem. 2001;276(21):17621–17624
   PubMed Web of Science ®Google Scholar
• . Shaul PW. Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol. 2002;64:749–774
   PubMed Web of Science ®Google Scholar
• . Lam CF, Peterson TE, Richardson DM, . Increased blood flow causes coordinated upregulation of arterial eNOS and biosynthesis of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol. 2006;290(2):H786–H793
   Web of Science ®Google Scholar
• . Corson MA, James NL, Latta SE, Nerem RM, Berk BC, Harrison DG. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res. 1996;79(5):984–991
   PubMed Web of Science ®Google Scholar
• . Rapoport RM, Draznin MB, Murad F. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature. 1983;306(5949):174–176
   PubMedGoogle Scholar
• . Förstermann U, Mülsch A, Böhme E, Busse R. Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ Res. 1986;58(4):531–538
   PubMed Web of Science ®Google Scholar
• . Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci. 2002;23(2):374–380
   PubMedGoogle Scholar
• . Halcox JP, Narayanan S, Cramer-Joyce L, Mincemoyer R, Quyyumi AA. Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation. Am J Physiol Heart Circ Physiol. 2001;80(6):H2470–H2477
   Google Scholar
• . Saye JA, Singer HA, Peach MJ. Role of endothelium in conversion of angiotensin I to angiotensin II in rabbit aorta. Hypertension. 1984;6(2 Pt 1):216–221
   PubMed Web of Science ®Google Scholar
• . Kinlay S, Behrendt D, Wainstein M, . Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries. Circulation. 2001;104(1):1114–1118
   PubMedGoogle Scholar
• . Nystrom FH, Quon MJ. Insulin signalling: Metabolic pathways and mechanisms for specificity. Cell Signal. 1999;11(8):563–574
   PubMed Web of Science ®Google Scholar
• . Ver MR CH, Quon MJ. Insulin signaling pathways regulating translocation of glut4. Curr Med Chem Immun Endo Metab Agents. 2005;5:159–165
   Google Scholar
• . Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23(2):168–175
   PubMed Web of Science ®Google Scholar
• . Potenza MA, Marasciulo FL, Chieppa DM, . Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am J Physiol Heart Circ Physiol. 2005;289(2):H813–H822
   PubMed Web of Science ®Google Scholar
• . Montagnani M, Golovchenko I, Kim I, . Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem. 2002;277(3):1794–1799
   PubMed Web of Science ®Google Scholar
• . Kelly LK, Wedgwood S, Steinhorn RH, Black SM. Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase. Am J Physiol Lung Cell Mol Physiol. 2004;286(5):L984–L991
   Web of Science ®Google Scholar
• . Muniyappa R, Iantorno M, Quon MJ. An integrated view of insulin resistance and endothelial dysfunction. Endocrinol Metab Clin North Am. 2008;37(3):685–711
   PubMed Web of Science ®Google Scholar
• . Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behaviour. J Am Coll Cardiol. 2007;49(25):2379–2393
   PubMed Web of Science ®Google Scholar
• . Murohara T, Asahara T, Silver M, . Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101(11):2567–2578
   PubMed Web of Science ®Google Scholar
• . Dimmeler S, Zeiher AM. Nitric oxide—an endothelial cell survival factor. Cell Death Differ. 1999;6(10):964–968
   PubMed Web of Science ®Google Scholar
• . Sasaki K, Heeschen C, Aicher A, . Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc Natl Acad Sci USA. 2006;103(39):14537–14541
   PubMed Web of Science ®Google Scholar
• . Landmesser U, Engberding N, Bahlmann FH, . Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation. 2004;110(14):1933–1939
   PubMed Web of Science ®Google Scholar
• . Xu J, Zou MH. Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation. 2009;120(13):1266–1286
   PubMed Web of Science ®Google Scholar
• . Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med. 1992;326(4):310–318
   PubMed Web of Science ®Google Scholar
• . Le Gouill E, Jimenez M, Binnert C, . Endothelial nitric oxide synthase (eNOS) knockout mice have defective mitochondrial beta-oxidation. Diabetes. 2007;56(11):2690–2696
   PubMed Web of Science ®Google Scholar
• . Duplain H, Burcelin R, Sartori C, . Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation. 2001;104(3):342–345
   PubMed Web of Science ®Google Scholar
• . Monti LD, Barlassina C, Citterio L, . Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes. 2003;52(5):1270–1275
   PubMed Web of Science ®Google Scholar
• . Miranda JA, Belo VA, Souza-Costa DC, Lanna CM, Tanus-Santos JE. eNOS polymorphism associated with metabolic syndrome in children and adolescents. Mol Cell Biochem. 2013;372(1–2):155–160
   PubMed Web of Science ®Google Scholar
• . Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA. 2004;291(16):1978–1986
   PubMed Web of Science ®Google Scholar
• . Meigs JB, O'Donnell CJ, Tofler GH, . Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes. 2006;55(2):530–537
   PubMed Web of Science ®Google Scholar
• . Alberti KG, Eckel RH, Grundy SM, ; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645
   PubMed Web of Science ®Google Scholar
• . Kahn R. Metabolic syndrome—what is the clinical usefulness. Lancet. 2008;371(9628):1892–1893
   PubMed Web of Science ®Google Scholar
• . Vykoukal D, Davies MG. Vascular biology of metabolic syndrome. J Vasc Surg. 2011;54(3):819–831
   PubMed Web of Science ®Google Scholar
• . Drexler AJ, Nesto RW, Abrahamson MJ, . Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome. Metab Syndr Relat Disord. 2005;3(2):147–173
   PubMed Web of Science ®Google Scholar
• . Tabit CE, Chung WB, Hamburg NM, Vita JA. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev Endocr Metab Disord. 2010;11(1):61–74
   PubMed Web of Science ®Google Scholar
• . Cusi K, Maezono K, Osman A, . Insulin resistance differentially affects the pi 3-kinase- and map kinase-mediated signaling in human muscle. J Clin Invest. 2000;105(3):311–320
   PubMed Web of Science ®Google Scholar
• . Jiang ZY, Lin YW, Clemont A, . Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest. 1999;104(4):447–457
   PubMed Web of Science ®Google Scholar
• . Wheatcroft SB, Williams IL, Shah AM, Kearney MT. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med. 2003;20(4):255–268
   PubMed Web of Science ®Google Scholar
• . Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the akt site. J Clin Invest. 2001;108(9):1341–1348
   PubMed Web of Science ®Google Scholar
• . Maloney E, Sweet IR, Hockenbery DM, . Activation of NF-kappaB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler Thromb Vasc Biol. 2009;29(9):1370–1375
   PubMed Web of Science ®Google Scholar
• . Rajagopalan S, Harrison DG. Reversing endothelial dysfunction with ACE inhibitors: a new trend? Circulation. 1996;94(3):240–243
   PubMed Web of Science ®Google Scholar
• . Barlovic DP, Soro-Paavonen A, Jandeleit-Dahm KA. RAGE biology, atherosclerosis and diabetes. Clin Sci (Lond). 2011;121(2):43–55
   PubMed Web of Science ®Google Scholar
• . Mudau M, Genis A, Lochner A, Strijdom H. Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc J Afr. 2012;23(4):222–231
   PubMed Web of Science ®Google Scholar
• . Zou MH, Shi C, Cohen RA. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest. 2002;109(6):817–826
   PubMed Web of Science ®Google Scholar
• . Munzel T, Daiber A, Ullrich V, Mulsch A. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol. 2005;25(8):1551–1557
   PubMed Web of Science ®Google Scholar
• . Dong F, Zhang X, Li SY, . Possible involvement of NADPH oxidase and JNK in homocysteine-induced oxidative stress and apoptosis in human umbilical vein endothelial cells. Cardiovasc Toxicol. 2005;5(1):9–20
   PubMed Web of Science ®Google Scholar
• . Recchioni R, Marcheselli F, Moroni F, Pieri C. Apoptosis in human aortic endothelial cells induced by hyperglycemic condition involves mitochondrial depolarization and is prevented by N-acetyl-L-cysteine. Metabolism. 2002;51(11):1384–1388
   PubMed Web of Science ®Google Scholar
• . Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102(1):42–47
   PubMed Web of Science ®Google Scholar
• . Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden TJ. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. Clin Endocrinol Metab. 1998;83(8):2907–2910
   Google Scholar
• . Molet S, Furukawa K, Maghazechi A, Hamid Q, Giaid A. Chemokine-and cytokine-induced expression of endothelin 1 and endothelin-converting enzyme 1 in endothelial cells. J Allergy Clin Immunol. 2000;105(2 Pt 1):333–338
   PubMed Web of Science ®Google Scholar
• . Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793–1801
   PubMed Web of Science ®Google Scholar
• . Read MA, Whitley MZ, Williams AJ, Collins T. NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J Exp Med. 1994;179(2):503–512
   PubMed Web of Science ®Google Scholar
• . de Alvaro C, Teruel T, Hernandez R, Lorenzo M. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem. 2004;279(17):17070–17078
   PubMed Web of Science ®Google Scholar
• . Xu B, Chibber R, Ruggerio D, Kohner E, Ritter J, Ferro A. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB J. 2003;17(15):1289–1291
   PubMedGoogle Scholar
• . Rojas A, Romay S, Gonzalez D, Herrera B, Delgado R, Otero K. Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products. Circ Res. 2000;86(3):E50–E54
   Web of Science ®Google Scholar
• . Yamagishi S, Fujimori H, Yonekura H, Yamamoto Y, Yamamoto H. Advanced glycation end-products inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia. 1989;41(12):1435–1441
   Google Scholar
• . Quehenberger P, Bierhaus A, Fasching P, . Endothelin 1 transcription is controlled by nuclear factor-kB in AGE-stimulated cultured endothelial cells. Diabetes. 2000;49(9):1561–1570
   PubMed Web of Science ®Google Scholar
• . Haffner SM. Abdominal adiposity and cardiometabolic risk: do we have all the answers? Am J Med. 2007;120(9 Suppl 1):S10–S17
   Web of Science ®Google Scholar
• . Silha JV, Krsek M, Sucharda P, Murphy LJ. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes (Lond). 2005;29(11):1308–1314
   PubMed Web of Science ®Google Scholar
• . Kim F, Tysseling KA, Rice J, . Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. Arterioscler Thromb Vasc Biol. 2005;25(5):989–994
   PubMed Web of Science ®Google Scholar
• . Wang XL, Zhang L, Youker K, . Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting akt kinase. Diabetes 2006;55(8):2301–2310
   PubMed Web of Science ®Google Scholar
• . Clavey V, Lestavel-Delattre S, Copin C, Bard JM, Fruchart JC. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E. Arterioscler Thromb Vasc Biol. 1995;15(7):963–971
   PubMed Web of Science ®Google Scholar
• . Kawakami A, Yoshida MJ. Apolipoprotein CIII links dyslipidemia with atherosclerosis. Atheroscler Thromb. 2009;16(1):6–11
   Google Scholar
• . Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272(34):20963–20966
   PubMed Web of Science ®Google Scholar
• . Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 1998;98(15):1487–1494
   PubMed Web of Science ®Google Scholar
• . Li D, Chen H, Romeo F, Sawamura T, Saldeen T, Mehta J. Statins modulate oxidized low-density lipoprotein mediated adhesion molecule expression in human coronary artery endothelial cells: a role of LOX-1. J Pharmacol Exp Ther. 2002;302(2):601–605
   PubMed Web of Science ®Google Scholar
• . Verhoye E, Langlois MR; Asklepios Investigators. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk? Clin Chem Lab Med. 2009;47(2):128–137
   PubMed Web of Science ®Google Scholar
• . Ma FX, Zhou B, Chen Z, . Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res. 2006;47(6):1227–1237
   PubMed Web of Science ®Google Scholar
• . Mehta J. Oxidized or native low density lipoprotein cholesterol. J Am Coll Cardiol. 2006;48(5):988–989
   Web of Science ®Google Scholar
• . Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem. 2003;278(45):45021–45026
   PubMed Web of Science ®Google Scholar
• . Motoshima H, Wu X, Mahadev K, Goldstein BJ. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun. 2004;315(2):264–271
   PubMed Web of Science ®Google Scholar
• . Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol. 2005;288(5):H2031–H2041
   PubMed Web of Science ®Google Scholar
• . Shimabukuro M, Higa N, Asahi T, . Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab. 2003;88(7):3236–3240
   PubMed Web of Science ®Google Scholar
• . Lam TY, Seto SW, Lau YM, . Impairment of the vascular relaxation and differential expression of caveolin-1 of the aorta of diabetic +db/+db mice. Eur J Pharmacol. 2006;546(1–3):134–141
   PubMed Web of Science ®Google Scholar
• . Bucci M, Roviezzo F, Brancaleone V, . Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression. Arterioscler Thromb Vasc Biol. 2004;24(4):721–726
   PubMed Web of Science ®Google Scholar
• . Das EN, King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res. 2007;55(6):498–510
   PubMed Web of Science ®Google Scholar
• . Lei H, Venkatakrishnan A, Yu S, Kazlauskas A. Protein kinase A-dependent translocation of Hsp90 alpha impairs endothelial nitric-oxide synthase activity in high glucose and diabetes. J Biol Chem. 2007;282(13):9364–9371
   PubMed Web of Science ®Google Scholar
• . Boger RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res. 2003;59(4):824–833
   PubMed Web of Science ®Google Scholar
• . El Midaoui A, de Champlain J. Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid. Hypertension. 2002;39(2):303–307
   PubMed Web of Science ®Google Scholar
• . Nisoli E, Clementi E, Paolucci C, . Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science. 2003;299(5608):896–899
   PubMed Web of Science ®Google Scholar
• . Nisoli E, Falcone S, Tonello C, . Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci USA. 2004;101(47):16507–16512
   PubMed Web of Science ®Google Scholar
• . Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005;307(5708):384–387
   PubMed Web of Science ®Google Scholar
• . Leeper NJ, Kullo IJ, Cooke JP. Genetics of peripheral artery disease. Circulation. 2012;125(25):3220–3228
   PubMed Web of Science ®Google Scholar
• . Poredos P, Jezovnik MK. Testing endothelial function and its clinical relevance. J Atheroscler Thromb. 2013;20(1):1–8
   PubMed Web of Science ®Google Scholar
• . Celermajer DS, Sorensen KE, Gooch VM, . Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340(8828):1111–1115
   PubMed Web of Science ®Google Scholar
• . Hamburg NM, Benjamin EJ. Assessment of endothelial function using digital pulse amplitude tonometry. Trends Cardiovasc Med. 2009;19(1):6–11
   PubMed Web of Science ®Google Scholar
• . Ghiadoni L, Versari D, Giannarelli C, Faita F, Taddei S. Non-invasive diagnostic tools for investigating endothelial dysfunction. Curr Pharm Des. 2008;14(35):3715–3722
   PubMed Web of Science ®Google Scholar
• . Landim MB, Casella Filho A, Chagas AC. Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis. Clinics (Sao Paulo). 2009;64(5):471–478
   PubMed Web of Science ®Google Scholar
• . Tsimikas S. Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease. Am J Cardiol. 2006;98(11 A):9P–17P
   Web of Science ®Google Scholar
• . Boos CJ, Blann AD, Lip GY. Assessment of endothelial damage/dysfunction: a focus on circulating endothelial cells. Methods Mol Med. 2007;139:211–224
   PubMedGoogle Scholar
• . Boos CJ, Balakrishnan B, Lip GY. The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction. Ann Med. 2008;40(1):66–73
   PubMed Web of Science ®Google Scholar
• . Corretti MC, Anderson TJ, Benjamin EJ, . International Brachial Artery Reactivity Task Force Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39(2):257–265
   PubMed Web of Science ®Google Scholar
• . Berry KL, Skyrme-Jones RAP, Meredith IT. Occlusion cuff position is an important determinant of the time course and magnitude of human brachial artery flow-mediated dilation. Clin Sci. 2000;99(4):261–267
   Web of Science ®Google Scholar
• . Betik AC, Luckham VB, Hughson RL. Flow-mediated dilation in human brachial artery after different circulatory occlusion conditions. Am J Physiol Heart Circ Physiol. 2004;286(1):H442–H448
   Web of Science ®Google Scholar
• . Bressler B, Chan S, Mancini GBJ. Temporal response of brachial artery dilation after occlusion and nitroglycerin. Am J Cardiol. 2002;85(3):391–394
   Web of Science ®Google Scholar
• . Polovina M, Potpara T, Giga V, Ostojić M. Significance of heterogeneity in endothelium-dependent vasodilatation occurrence in healthy individuals with or without coronary risk factors. Vojnosanit Pregl. 2009;66(10):813–820
   PubMedGoogle Scholar
• . Parker BA, Ridout SJ, Proctor DN. Age and flow-mediated dilation: a comparison of dilatory responsiveness in the brachial and popliteal arteries. Am J Physiol Heart Circ Physiol. 2006;291(6):H3043–H3049
   Web of Science ®Google Scholar
• . Freestone B, Chong AY, Nuttall S, Lip GY. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels. Thromb Res. 2008;122(1):85–90
   PubMed Web of Science ®Google Scholar
• . Polovina M, Potpara T, Giga V, Stepanovic J, Ostojic MC. Impaired endothelial function in lone atrial fibrillation. Vojnosanit Pregl. 2013;70(10):908–914
   PubMed Web of Science ®Google Scholar
• . Lekakis J, Abraham P, Balbarini A, . Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation. Eur J Cardiovasc Prev Rehabil. 2011;18(6):775–789
   PubMed Web of Science ®Google Scholar
• . Thijssen DH, Black MA, Pyke KE, . Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol. 2011;300(1):H2–H12
   PubMed Web of Science ®Google Scholar
• . Woodman RJ, Playford DA, Watts GF, . Improved analysis of brachial artery ultrasound using a novel edge-detection software system. J Appl Physiol. 2001;91(2):929–937
   PubMed Web of Science ®Google Scholar
• . Takase B, Uehata A, Akima T, . Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol. 1998;82(12):1535–1539, A7–A8
   PubMed Web of Science ®Google Scholar
• . Felmeden DC, Blann AD, Spencer CG, Beevers DG, Lip GY. A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. Blood Coagul Fibrinolysis. 2003;14(5):425–431
   PubMed Web of Science ®Google Scholar
• . Brevetti G, Silvestro A, Di Giacomo S, . Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg. 2003;38(2):374–379
   PubMed Web of Science ®Google Scholar
• . Chong AY, Blann AD, Patel J, Freestone B, Hughes E, Lip GY. Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide. Circulation. 2004;110(13):1794–1798
   PubMed Web of Science ®Google Scholar
• . Ludmer PL, Selwyn AP, Shook TL, . Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315(17):1046–1051
   PubMed Web of Science ®Google Scholar
• . Cox DA, Vita JA, Treasure CB, . Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation. 1989;80(3):458–465
   PubMed Web of Science ®Google Scholar
• . Corretti MC, Anderson TJ, Benjamin EJ, ; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39(2):257–265
   PubMed Web of Science ®Google Scholar
• . Joannides R, Haefeli WE, Linder L, . Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91(5):1314–1319
   PubMed Web of Science ®Google Scholar
• . Lieberman EH, Gerhard MD, Uehata A, . Flow-induced vasodilation of the human brachial artery is impaired in patients < 40 years of age with coronary artery disease. Am J Cardiol. 1996;78(11):1210–1214
   PubMed Web of Science ®Google Scholar
• . Neunteufl T, Heher S, Katzenschlager R, Wölfl G, Kostner K, Maurer G, Weidinger F. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol. 2000;86(2):207–210
   PubMed Web of Science ®Google Scholar
• . Kitta Y, Obata JE, Nakamura T, . Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol. 2009;53(4):323–330
   PubMed Web of Science ®Google Scholar
• . Karatzis EN, Ikonomidis I, Vamvakou GD, . Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation. Am J Cardiol. 2006;98(11):1424–1428
   PubMed Web of Science ®Google Scholar
• . Akcakoyun M, Kargin R, Tanalp AC, . Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study. Coron Artery Dis. 2008;19(5):337–343
   PubMed Web of Science ®Google Scholar
• . Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101(9):948–954
   PubMed Web of Science ®Google Scholar
• . Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101(16):1899–1906
   PubMed Web of Science ®Google Scholar
• . Blann AD, McCollum CN. von Willebrand factor and soluble thrombomodulin as predictors of adverse events among subjects with peripheral or coronary atherosclerosis. Blood Coagul Fibrinolysis. 1999;10(6):375–380
   PubMed Web of Science ®Google Scholar
• . Patti G, Pasceri V, Melfi R, . Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation. 2005;111(1):70–75
   PubMed Web of Science ®Google Scholar
• . Brevetti G, Schiano V, Chiariello M. Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease? Atherosclerosis. 2008;197(1):1–11
   PubMed Web of Science ®Google Scholar
• . Pradhan AD, Rifai N, Ridker PM. Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation. 2002;106(7):820–825
   PubMed Web of Science ®Google Scholar
• . Brevetti G, De Caterina M, Martone VD, . Exercise increases soluble adhesion molecules ICAM-1 and VCAM-1 in patients with intermittent claudication. Clin Hemorheol Microcirc. 2001;24(3):193–199
   PubMed Web of Science ®Google Scholar
• . Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation. 2003;108(17):2093–2098
   PubMed Web of Science ®Google Scholar
• . Perrone-Filardi P, Cuocolo A, Brevetti G, . Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease. Am J Cardiol. 2005;96(9):1337–1344
   PubMed Web of Science ®Google Scholar
• . Pellegrino T, Storto G, Filardi PP, . Relationship between brachial artery flow-mediated dilation and coronary flow reserve in patients with peripheral artery disease. J Nucl Med. 2005;46(12):1997–2002
   PubMed Web of Science ®Google Scholar
• . Silvestro A, Brevetti G, Schiano V, Scopacasa F, Chiariello M. Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification. Thromb Haemost. 2005;93(3):559–563
   PubMed Web of Science ®Google Scholar
• . Gokce N, Keaney Jr JF, Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation. 2002;105(13):1567–1572
   PubMed Web of Science ®Google Scholar
• . Gokce N, Keaney JF Jr, Hunter LM, . Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol. 2003;41(10):1769–1775
   PubMed Web of Science ®Google Scholar
• . Huang AL, Silver AE, Shvenke E, . Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol. 2007;27(10):2113–2119
   PubMed Web of Science ®Google Scholar
• . Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol. 2002;40(3):505–510
   PubMed Web of Science ®Google Scholar
• . Schindler TH, Hornig B, Buser PT, . Prognostic value of abnormal vasoreactivity of epicardial coronary arteries to sympathetic stimulation in patients with normal coronary angiograms. Arterioscler Thromb Vasc Biol. 2003;23(3):495–501
   PubMed Web of Science ®Google Scholar
• . Arnlöv J, Ingelsson E, Sundström J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010;121(2):230–236
   PubMed Web of Science ®Google Scholar
• . Noda H, Iso H, Saito I, Konishi M, Inoue M, Tsugane S; JPHC Study Group. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study. Hypertens Res. 2009;32(4):289–298
   PubMed Web of Science ®Google Scholar
• . Naylor LH, Green DJ, Jones TW, . Endothelial function and carotid intima-medial thickness in adolescents with type 2 diabetes mellitus. J Pediatr. 2011;159(6):971–974
   PubMed Web of Science ®Google Scholar
• . Nitenberg A, Pham I, Antony I, Valensi P, Attali JR, Chemla D. Cardiovascular outcome of patients with abnormal coronary vasomotion and normal coronary arteriography is worse in type 2 diabetes mellitus than in arterial hypertension: a 10 year follow-up study. Atherosclerosis. 2005;183(1):113–120
   PubMed Web of Science ®Google Scholar
• . Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002;106(16):2085–2090
   PubMed Web of Science ®Google Scholar
• . Suzuki T, Hirata K, Elkind MS, . Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS). Am Heart J. 2008;156(2):405–410
   PubMed Web of Science ®Google Scholar
• . Meeking DR, Cummings MH, Thorne S, . Endothelial dysfunction in Type 2 diabetic subjects with and without microalbuminuria. Diabet Med. 1999;16(10):841–847
   PubMed Web of Science ®Google Scholar
• . Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S. Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care. 2009;32( Suppl 2):S314–S321. doi:10.2337/dc09-S330
   PubMed Web of Science ®Google Scholar
• . Laurenti O, Vingolo EM, Desideri GB, . Increased levels of plasma endothelin-1 in non-insulin dependent diabetic patients with retinopathy but without other diabetes-related organ damage. Exp Clin Endocrinol Diabetes. 1997;105( Suppl 2):40–42
   PubMed Web of Science ®Google Scholar
• . Roberts CK, Barnard RJ, Jasman A, Balon TW Acute exercise increases nitric oxide synthase activity in skeletal muscle. Am J Physiol. 1999;277(2 Pt 1):E390–E394
   Google Scholar
• . Adams V, Linke A, Kränkel N, . Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation. 2005;111(5):555–562
   PubMed Web of Science ®Google Scholar
• . Siasos G, Tousoulis D, Tsigkou V, . Flavonoids in atherosclerosis: an overview of their mechanisms of action. Curr Med Chem. 2013;20(21):2641–2660
   PubMed Web of Science ®Google Scholar
• . Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A. Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs. 2002;62(2):265–284
   PubMed Web of Science ®Google Scholar
• . Sládková M, Kojsová S, Jendeková L, Pechánová O. Chronic and acute effects of different antihypertensive drugs on femoral artery relaxation of L-NAME hypertensive rats. Physiol Res. 2007;56( Suppl 2):S85–S91
   PubMed Web of Science ®Google Scholar
• . Zepeda RJ, Castillo R, Rodrigo R, . Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension. Basic Clin Pharmacol Toxicol. 2012;111(5):309–316
   PubMed Web of Science ®Google Scholar
• . Radenković M, Stojanović M, Potpara T, Prostran M. Therapeutic approach in the improvement of endothelial dysfunction: the current state of the art. Biomed Res Int. 2013;2013:252158. doi:10.1155/2013/252158
   PubMed Web of Science ®Google Scholar
• . Kayaalti F, Kalay N, Basar E, . Effects of nebivolol therapy on endothelial functions in cardiac syndrome X. Heart Vessels. 2010;25(2):92–96
   PubMed Web of Science ®Google Scholar
• . Xiaozhen H, Yun Z, Mei Z, Yu S. Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy. Blood Press. 2010;19(1):40–47
   PubMed Web of Science ®Google Scholar
• . Chłopicki S, Gryglewski RJ. Angiotensin converting enzyme (ACE) and hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium. Pharmacol Rep. 2005;57( Suppl):86–96
   PubMed Web of Science ®Google Scholar
• . Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 1998;97(12):1129–1135
   PubMed Web of Science ®Google Scholar
• . Spyridopoulos I, Haendeler J, Urbich C, . Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation. 2004;110(19):3136–3142
   PubMed Web of Science ®Google Scholar
• . Sadowitz B, Maier KG, Gahtan V. Basic science review: statin therapy—part I: the pleiotropic effects of statins in cardiovascular disease. Vasc Endovascular Surg. 2010;44(4):241–251
   PubMed Web of Science ®Google Scholar
• . Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995;332(8):488–493
   PubMed Web of Science ®Google Scholar
• . Dahmus JD, Bruning RS, Kenney WL, Alexander LM. Oral clopidogrel improves cutaneous microvascular function through EDHF-dependent mechanisms in middle-age humans. Am J Physiol Regul Integr Comp Physiol. 2013;305(4):R452–R458
   Web of Science ®Google Scholar
• . Potpara TS, Lip GY. Current therapeutic strategies and future perspectives for the prevention of arterial thromboembolism: focus on atrial fibrillation. Curr Pharm Des. 2010;16(31):3455–3471
   PubMed Web of Science ®Google Scholar
• . Potpara TS, Lip GY. New anticoagulation drugs for atrial fibrillation. Clin Pharmacol Ther. 2011;90(4):502–506
   PubMed Web of Science ®Google Scholar
• . Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. Adv Ther. 2012;29(6):491–507. doi:10.1007/s12325-012-0026-8
   PubMed Web of Science ®Google Scholar
• . Caballero AE, Saouaf R, Lim SC, . The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial. Metabolism. 2003;52(2):173–180
   PubMed Web of Science ®Google Scholar
• . Forst T, Lübben G, Hohberg C, . Influence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mellitus type 2. Microcirculation. 2005;12(7):543–550
   PubMed Web of Science ®Google Scholar
• . Stuhlinger MC, Abbasi F, Chu JW, . Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA. 2002;287(11):1420–1426
   PubMed Web of Science ®Google Scholar
• . Ceriello A. Thiazolidinediones as anti-inflammatory and anti-atherogenic agents. Diabete Metab Res Rev. 2008;24(1):14–26
   PubMed Web of Science ®Google Scholar
• . de Aguiar LG, Bahia LR, Villela N, . Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance. Diabetes Care. 2006;29(5):1083–1089
   PubMed Web of Science ®Google Scholar
• . Vitale C, Mercuro G, Cornoldi A, Fini M, Volterrani M, Rosano GM. Metformin improves endothelial function in patients with metabolic syndrome. J Intern Med. 2005;258(3):250–256
   PubMed Web of Science ®Google Scholar
• . Mamputu JC, Wiernsperger NF, Renier G. Antiatherogenic properties of metformin: the experimental evidence. Diabetes Metab. 2003;29(pt 2):6S71–6S76
   PubMed Web of Science ®Google Scholar
• . Chen LL, Yu F, Zeng TS, Liao YF, Li YM, Ding HC. Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes. Eur J Pharmacol. 2011;659(2–3):296–301
   PubMed Web of Science ®Google Scholar
• . Abbas A, Blandon J, Rude J, Elfar A, Mukherjee D. PPAR-γ agonist in treatment of diabetes: cardiovascular safety considerations. Cardiovasc Hematol Agents Med Chem. 2012;10(2):124–134
   PubMedGoogle Scholar